Rx ToMORROW® Dry Cow Intramammary Infusion
cephapirin benzathine intramammary infusion
ToMORROW® Dry Cow is a proven intramammary mastitis treatment formulated specifically for use in dairy cows during the dry period. Containing cephapirin benzathine, this long-acting antibiotic therapy helps eliminate existing mastitis infections and protect udder health prior to calving.
Each 10 mL syringe delivers 300 mg of cephapirin activity suspended in a stable peanut oil gel, allowing for sustained antibacterial action throughout the dry period. ToMORROW® is recommended for cows known to harbor mastitis-causing organisms at drying off and has been shown effective against Streptococcus agalactiae and Staphylococcus aureus, including penicillin-resistant strains.
Features:
- For intramammary infusion in dry cows only
- Contains cephapirin benzathine for long-lasting mastitis control
- Effective against Streptococcus agalactiae and Staphylococcus aureus
- Opti-Sert® protective cap allows partial or full teat insertion
- Helps treat existing infections and protect udder health during the dry period
Directions for Use:
Use at the time of drying off. Completely milk out all four quarters. Wash and dry the udder and teats thoroughly, then scrub each teat end with 70% alcohol using a separate swab for each teat.
Infuse one full 10 mL syringe into each quarter. Use the Opti-Sert® protective cap for partial or full insertion as desired. After infusion, gently massage each quarter to distribute the medication evenly. Do not use if the Opti-Sert® cap is broken or damaged.
Do not use later than 30 days before calving.
Package Contents:
- 12 × 10 mL intramammary syringes
- 12 alcohol prep pads
Withdrawal Information:
Milk from treated cows must not be used for food during the first 72 hours after calving. Animals must not be slaughtered for food until 42 days after the last infusion.
Warnings & Precautions:
For use in dry cows only. Do not use within 30 days of calving. Use with caution in animals with known hypersensitivity to cephalosporins or penicillin. Consult a veterinarian if an allergic reaction occurs.
PLEASE NOTE:
The U.S. Food and Drug Administration (FDA) issued a final rule on July 3, 2008 prohibiting the extra-label use of cephalosporins (including ceftiofur in swine) in food-producing animals. The agency is issuing this order based on evidence that extra label use of these drugs in food-producing animals will likely cause an adverse event in humans and, as such, presents a risk to the public health. Public comment regarding the rule will be accepted until September 2, 2008 and the rule will go into effect on October 1, 2008.
This action would add cephalosporin antimicrobials to the list of drugs prohibited for extra-label use by the FDA. Given the recent approval of Baytril® for use in swine, it is important to remember that it too is among another class of drugs, fluoroquinolones, that are also prohibited for extra-label use in food animals.
Under the Animal Medicinal Drug Use Clarification Act (AMDUCA) drugs on this list may not be used under any circumstances in an extra-label manner even by a veterinarian.
This product requires a Valid prescription.
All prescription items are Non-Refundable and Non-Returnable.
